| 1 |
Bhattacharyya S, Ghosh H, Covarrubias-zambrano O, Jain K, Swamy KV, Kasi A, Hamza A, Anant S, Vansaun M, Weir SJ, Bossmann SH, Padhye SB, Dandawate P. Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. IJMS 2023;24:6336. [DOI: 10.3390/ijms24076336] [Reference Citation Analysis]
|
| 2 |
Khan MA, Khan P, Ahmad A, Fatima M, Nasser MW. FOXM1: A small fox that makes more tracks for cancer progression and metastasis. Semin Cancer Biol 2023:S1044-579X(23)00048-2. [PMID: 36958703 DOI: 10.1016/j.semcancer.2023.03.007] [Reference Citation Analysis]
|
| 3 |
Nagaraju GP, Farran B, Luong T, El-Rayes BF. Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview. Semin Cancer Biol 2023;88:67-80. [PMID: 36535506 DOI: 10.1016/j.semcancer.2022.12.004] [Reference Citation Analysis]
|
| 4 |
Khan FB, Singh P, Jamous YF, Ali SA, Abdullah, Uddin S, Zia Q, Jena MK, Khan M, Owais M, Huang CY, Chanukuppa V, Ardianto C, Ming LC, Alam W, Khan H, Ayoub MA. Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. Cancers (Basel) 2022;15. [PMID: 36612248 DOI: 10.3390/cancers15010249] [Reference Citation Analysis]
|
| 5 |
Noorani S, Nelson SR, Conlon NT, Meiller J, Shcheglova E, Usai A, Stoof J, Palanga L, O’neill F, Roche S, Cotter MB, Swan N, Walsh N. Pancreatic Cancer 3D Cell Line Organoids (CLOs) Maintain the Phenotypic Characteristics of Organoids and Accurately Reflect the Cellular Architecture and Heterogeneity In Vivo. Organoids 2022;1:168-183. [DOI: 10.3390/organoids1020013] [Reference Citation Analysis]
|
| 6 |
Kim EY, Lee SU, Kim YH. 1,2,3,4,6-Penta-O-galloyl-β-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell line. Anim Cells Syst (Seoul) 2022;26:328-37. [PMID: 36605595 DOI: 10.1080/19768354.2022.2152864] [Reference Citation Analysis]
|
| 7 |
Mukherjee AG, Wanjari UR, Gopalakrishnan AV, Bradu P, Sukumar A, Patil M, Renu K, Dey A, Vellingiri B, George A, Ganesan R. Implications of cancer stem cells in diabetes and pancreatic cancer. Life Sci 2022;312:121211. [PMID: 36414089 DOI: 10.1016/j.lfs.2022.121211] [Reference Citation Analysis]
|
| 8 |
Sher G, Masoodi T, Patil K, Akhtar S, Kuttikrishnan S, Ahmad A, Uddin S. Dysregulated FOXM1 signaling in the regulation of cancer stem cells. Semin Cancer Biol 2022;86:107-21. [PMID: 35931301 DOI: 10.1016/j.semcancer.2022.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 9 |
Jia SN, Han YB, Yang R, Yang ZC. Chemokines in colon cancer progression. Semin Cancer Biol 2022;86:400-7. [PMID: 35183412 DOI: 10.1016/j.semcancer.2022.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 10 |
Ferrara B, Dugnani E, Sordi V, Pasquale V, Pellegrini S, Reni M, Balzano G, Piemonti L. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2022;23. [PMID: 36142575 DOI: 10.3390/ijms231810663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Zeng Y, Zhang H, Zhu M, Pu Q, Li J, Hu X. β-Hydroxyisovaleryl-Shikonin Exerts an Antitumor Effect on Pancreatic Cancer Through the PI3K/AKT Signaling Pathway. Front Oncol 2022;12:904258. [DOI: 10.3389/fonc.2022.904258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Karthika C, Sureshkumar R, Zehravi M, Akter R, Ali F, Ramproshad S, Mondal B, Tagde P, Ahmed Z, Khan FS, Rahman MH, Cavalu S. Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein. Life (Basel) 2022;12:897. [PMID: 35743927 DOI: 10.3390/life12060897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Gajate C, Gayet O, Fraunhoffer NA, Iovanna J, Dusetti N, Mollinedo F. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition. Cancers (Basel) 2021;13:6124. [PMID: 34885233 DOI: 10.3390/cancers13236124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Palamaris K, Felekouras E, Sakellariou S. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance. Cancers (Basel) 2021;13:5532. [PMID: 34771695 DOI: 10.3390/cancers13215532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Basu M, Philipp LM, Baines JF, Sebens S. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer. Front Oncol 2021;11:740606. [PMID: 34631577 DOI: 10.3389/fonc.2021.740606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
